Cargando…

Fibrosing Progressive Interstitial Lung Disease in Rheumatoid Arthritis: A Multicentre Italian Study

Background: The INBUILD study demonstrated the efficacy of nintedanib in the treatment of progressive fibrosing interstitial lung disease different to idiopathic pulmonary fibrosis, including rheumatoid arthritis (RA)-related ILD. Nevertheless, the prevalence of RA-ILD patients that may potentially...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sebastiani, Marco, Venerito, Vincenzo, Laurino, Elenia, Gentileschi, Stefano, Atzeni, Fabiola, Canofari, Claudia, Andrisani, Dario, Cassone, Giulia, Lavista, Marlea, D’Alessandro, Francesco, Vacchi, Caterina, Scardapane, Arnaldo, Frediani, Bruno, Cazzato, Massimiliano, Salvarani, Carlo, Iannone, Florenzo, Manfredi, Andreina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672076/ https://www.ncbi.nlm.nih.gov/pubmed/38002655 http://dx.doi.org/10.3390/jcm12227041

Ejemplares similares

Radiomics to predict the mortality of patients with rheumatoid arthritis-associated interstitial lung disease: A proof-of-concept study
por: Venerito, Vincenzo, et al.
Publicado: (2023)

Evolution of Rheumatoid-Arthritis-Associated Interstitial Lung Disease in Patients Treated with JAK Inhibitors: A Retrospective Exploratory Study
por: Venerito, Vincenzo, et al.
Publicado: (2023)

Tofacitinib for the Treatment of Severe Interstitial Lung Disease Related to Rheumatoid Arthritis
por: Vacchi, Caterina, et al.
Publicado: (2021)

Combination Therapy with Nintedanib and Sarilumab for the Management of Rheumatoid Arthritis Related Interstitial Lung Disease
por: Vacchi, Caterina, et al.
Publicado: (2020)

Pirfenidone for the treatment of interstitial lung disease associated to rheumatoid arthritis: a new scenario is coming?
por: Cassone, Giulia, et al.
Publicado: (2020)

Efficacy and safety of rituximab in the treatment of connective tissue disease-related interstitial lung disease
por: Vacchi, Caterina, et al.
Publicado: (2021)

Efficacy and safety of mycophenolate mofetil in the treatment of rheumatic disease-related interstitial lung disease: a narrative review
por: Cassone, Giulia, et al.
Publicado: (2021)

Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study
por: Cassone, Giulia, et al.
Publicado: (2020)

Immunogenicity and Safety of Adjuvanted Recombinant Zoster Vaccine in Rheumatoid Arthritis Patients on Anti-Cellular Biologic Agents or JAK Inhibitors: A Prospective Observational Study
por: Venerito, Vincenzo, et al.
Publicado: (2023)

Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Lights and Shadows
por: Cassone, Giulia, et al.
Publicado: (2020)

Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review
por: Vacchi, Caterina, et al.
Publicado: (2020)

Diagnosis, Clinical Features and Management of Interstitial Lung Diseases in Rheumatic Disorders: Still a Long Journey
por: Sebastiani, Marco, et al.
Publicado: (2022)

Personalized Medicine and Machine Learning: A Roadmap for the Future
por: Sebastiani, Marco, et al.
Publicado: (2022)

Interstitial Pneumonia with Autoimmune Features: Why Rheumatologist-Pulmonologist Collaboration Is Essential
por: Sebastiani, Marco, et al.
Publicado: (2020)

Rheumatoid Arthritis from Easy to Complex Disease: From the “2022 GISEA International Symposium”
por: Perniola, Simone, et al.
Publicado: (2023)

Usefulness of digital velcro crackles detection in identification of interstitial lung disease in patients with connective tissue diseases
por: MANFREDI, Andreina, et al.
Publicado: (2020)

Erratum to acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: a prospective study and review of the literature
por: Manfredi, Andreina, et al.
Publicado: (2020)

COVID-19, rheumatic diseases and immunosuppressive drugs: an appeal for medication adherence
por: Venerito, Vincenzo, et al.
Publicado: (2020)

Management of Takayasu arteritis diagnosed during pregnancy: A case report
por: AREZZO, Francesca, et al.
Publicado: (2020)

AI am a rheumatologist: a practical primer to large language models for rheumatologists
por: Venerito, Vincenzo, et al.
Publicado: (2023)

VECTOR: An algorithm for the detection of COVID-19 pneumonia from velcro-like lung sounds
por: Pancaldi, Fabrizio, et al.
Publicado: (2022)

Cytokine Signatures in Mucocutaneous and Ocular Behçet’s Disease
por: Lopalco, Giuseppe, et al.
Publicado: (2017)

Update on the Medical Management of Gastrointestinal Behçet's Disease
por: Lopalco, Giuseppe, et al.
Publicado: (2017)

Axial Spondyloarthritis: Reshape the Future—From the “2022 GISEA International Symposium”
por: Salaffi, Fausto, et al.
Publicado: (2022)

From Bench to Bedside in Rheumatoid Arthritis from the “2022 GISEA International Symposium”
por: Vitale, Antonio, et al.
Publicado: (2023)

Comparison of Adalimumab to Other Targeted Therapies in Rheumatoid Arthritis: Results from Systematic Literature Review and Meta-Analysis
por: Cacciapaglia, Fabio, et al.
Publicado: (2022)

Arthritis in Systemic Lupus Erythematosus: From 2022 International GISEA/OEG Symposium
por: Ceccarelli, Fulvia, et al.
Publicado: (2022)

Neurologic Complications Associated with Sjögren's Disease: Case Reports and Modern Pathogenic Dilemma
por: Colaci, Michele, et al.
Publicado: (2014)

Carotidynia Possibly due to Localized Vasculitis in a Patient with Latent Mycobacterium tuberculosis Infection
por: Cassone, Giulia, et al.
Publicado: (2013)

Lung complications of Sjogren syndrome
por: Luppi, Fabrizio, et al.
Publicado: (2020)

Antifibrotic drugs in connective tissue disease-related interstitial lung disease (CTD-ILD): from mechanistic insights to therapeutic applications
por: Erre, Gian Luca, et al.
Publicado: (2021)

Long-Term Effectiveness of Secukinumab in Patients with Axial Spondyloarthritis
por: Gentileschi, Stefano, et al.
Publicado: (2020)

ReLiFiRa (Real Life Filgotinib in Rheumatoid Arthritis): Retrospective Study of Efficacy and Safety in Common Clinical Practice
por: Benucci, Maurizio, et al.
Publicado: (2023)

Clinical and Serological Characteristics of a Monocentric Cohort of Patients Affected by Interstitial Pneumonia with Autoimmune Features (IPAF)
por: Canofari, Claudia, et al.
Publicado: (2023)

A Machine Learning Approach to Predict Remission in Patients With Psoriatic Arthritis on Treatment With Secukinumab
por: Venerito, Vincenzo, et al.
Publicado: (2022)

Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature
por: Colaci, M., et al.
Publicado: (2015)

Extra-Articular Manifestations and Comorbidities in Psoriatic Disease: A Journey Into the Immunologic Crosstalk
por: Novelli, Lucia, et al.
Publicado: (2021)

Fibrositis /
por: Zamundio Fernández, María Guadalupe
Publicado: (1990)

Fibrositis
Publicado: (1913)

Fibrositis
por: Gordon, R. G.
Publicado: (1925)

Cannot write session to /tmp/vufind_sessions/sess_q6rs9l58ff55nhtm6ekhs5b7s7